Werum Software & Systems, a leading supplier of Manufacturing Execution Systems (MES) for the pharmaceutical and biopharmaceutical industries has signed a Global MES Master Agreement with Merck Serono.
According to the agreement, Merck Serono is planning to implement standardised MES solutions for both its pharmaceutical and biotechnological lines of production using Werum's MES products PAS-X PHARMA and PAS-X BIOTECH as a basis.
Merck Serono placed an initial order for two parallel MES projects. Werum will deploy PAS-X PHARMA at the pharmaceutical site in Darmstadt, Germany; simultaneously, Merck Serono will equip a new biotech plant in Vevey in Switzerland with PAS-X BIOTECH. Once these two projects have been completed successfully, PAS-X will gradually be rolled out to other sites worldwide, starting with Semoy (France) and Mexico.
Consistent project procedures - especially for qualification and validation of the system - along with uniform production business processes at the sites are expected to bring Merck Serono three major benefits: reduced production risks, considerably shorter time needed for documentation and much faster release of manufacturing reports.